Dr Mark Gaze

Tackling Neuroblastoma

Dr Mark Gaze from University College Hospital and Great Ormond Street Hospital for Children in London is leading vital clinical trials for children with neuroblastoma, which is one of the most common childhood cancers.

Dr Gaze is currently running a clinical trial called LuDo. The trial is finding out whether a drug used to treat some adult cancers, called 177Lu DOTATATE, is safe and effective for children with neuroblastoma. The treatment works like a guided missile, delivering radiation directly to the cancer cells.

He is also developing another Cancer research UK funded trial to find out if a new, more targeted form of radiotherapy improves survival for children with neuroblastoma.

Neuroblastoma can be hard to treat, so finding new ways to tackle it is really important. Dr Gaze’s research could provide more options for treating neuroblastoma, ensuring more children survive the disease.

Read more about the LuDo trial here: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2014-01-30-new-treatment-hope-for-one-of-the-deadliest-childhood-cancers

Children's cancers
Neuroblastoma
Clinical trials
Radiotherapy research

University College London Hospitals NHS Foundation Trust, London

mark.gaze@uclh.nhs.uk

lab website